The class of chemicals identified as VAMP-3 activators encompasses a variety of compounds known for their roles in modulating signaling pathways and cellular processes crucial for vesicular transport and membrane fusion. These activators do not directly interact with VAMP-3 but are thought to modulate the cellular and molecular context in a way that could enhance VAMP-3's activity. One primary mechanism through which these compounds may activate VAMP-3 involves the modulation of cellular signaling pathways that are directly related to vesicle trafficking and fusion. Compounds like Phorbol 12-myristate 13-acetate (PMA) and Forskolin, which activate PKC and PKA respectively, enhance the function of VAMP-3 by promoting processes critical for vesicle fusion. The influence of calcium levels in vesicular transport is also significant, as seen with ionomycin and calcium channel agonists, which can enhance VAMP-3 function by elevating intracellular calcium, a key regulator of vesicle fusion.
Another aspect of VAMP-3 activation by these compounds is their impact on broader cellular metabolic and growth pathways. Insulin can indirectly activate VAMP-3 by enhancing cellular metabolism, which is closely tied to vesicle dynamics. Additionally, cGMP analogs and adenosine, which activate PKG and various signaling pathways, respectively, can contribute to enhancing VAMP-3's role in membrane fusion processes. The effectiveness of these compounds in activating VAMP-3 depends on various factors, including the specific cellular context, the concentration, and duration of exposure, and the presence of other interacting molecules. While these compounds provide valuable insights into the regulation of VAMP-3 activity, their role in specifically modulating VAMP-3-mediated processes warrants further experimental investigation in relevant biological models.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which is involved in vesicle transport. Activation of PKC can lead to the enhanced function of VAMP-3 by promoting vesicle fusion processes. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin increases cAMP levels, activating PKA. PKA activation can potentially enhance VAMP-3 function by influencing vesicular trafficking and membrane fusion processes. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin, a calcium ionophore, increases intracellular calcium levels, which are crucial for vesicle fusion. Elevated calcium can activate VAMP-3 by enhancing its role in vesicular transport. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Bromo-cAMP, a cAMP analog, activates PKA. PKA can then potentially enhance VAMP-3 activity by modulating vesicular trafficking pathways. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin can activate various signaling pathways, including those related to vesicle transport. It might indirectly activate VAMP-3 by enhancing cellular metabolism and vesicle dynamics. | ||||||
8-Bromoguanosine 3′, 5′ -cyclic monophosphoric acid | 31356-94-2 | sc-291685 sc-291685A | 5 mg 10 mg | $116.00 $206.00 | ||
cGMP analogs activate PKG, which can influence vesicular transport. Activation of PKG might enhance VAMP-3 function in membrane fusion processes. | ||||||
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $34.00 $48.00 $300.00 $572.00 $1040.00 $2601.00 $4682.00 | 1 | |
Adenosine activates several signaling pathways, potentially enhancing VAMP-3 activity by modulating vesicular transport and membrane fusion. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
Calcium channel agonists increase intracellular calcium, crucial for vesicle fusion. This elevation can activate VAMP-3 by enhancing its role in vesicular transport. | ||||||